Clinical Trials Logo

Severely Burned Patients clinical trials

View clinical trials related to Severely Burned Patients.

Filter by:
  • Recruiting  
  • Page 1

NCT ID: NCT02537821 Recruiting - Clinical trials for Severely Burned Patients

HLA Sensitization in Severely Burned Patients

Start date: June 2015
Phase: N/A
Study type: Observational

Primary goal of this study is the analysis of HLA (Human leucocyte antigen) formation in severly burned patients. Potential HLA triggers in the treatment of severely burned patients are blood products, assist devices or temporary allogeneic skin. Besides that, inflammatory markers, such as WBC (white blood cell count), CRP (C-reactive protein), PCT (Procalcitonin) and two novel biomarkers (PSP (pancreatic stone protein), ST2) are to be investigated in severely burned patients.